IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KAMALAKAR RAMBHATLA

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1932130663
CMS profile
987854
Location
EL MONTE, CA

General Payments · PY2018–2024

$7,395.67

  • Reported across 170 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,153.09

50 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Pulmonary Disease CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,073.15 49
Education $79.94 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $313.36 13
Regeneron Healthcare Solutions, Inc. $239.23 8
GlaxoSmithKline, LLC. $170.93 15
Actelion Pharmaceuticals US, Inc. $133.52 1
Boehringer Ingelheim Pharmaceuticals, Inc. $95.23 4
Merck Sharp & Dohme Corporation $42.14 2
Bayer HealthCare Pharmaceuticals Inc. $32.35 1
Mylan Specialty L.P. $31.17 1
Lilly USA, LLC $24.25 1
Genentech USA, Inc. $22.64 1
Philips Electronics North America Corporation $17.85 1
GENZYME CORPORATION $15.74 1
Amgen Inc. $14.68 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $108.89 8
PY2019 $484.51 24
PY2020 $3,752.21 12
PY2021 $250.24 8
PY2022 $572.58 26
PY2023 $1,074.15 42
PY2024 $1,153.09 50

Payment records · PY2024 (50)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $133.52 12/03/2024 Food and Beverage Undisputed 01/23/2026 1078867814 CMS
Amgen Inc. $14.68 06/28/2024 Food and Beverage Undisputed 01/23/2026 1111682973 CMS
AstraZeneca Pharmaceuticals LP $26.41 05/17/2024 Food and Beverage Undisputed 01/23/2026 1104200575 CMS
AstraZeneca Pharmaceuticals LP $20.42 05/24/2024 Food and Beverage Undisputed 01/23/2026 1105599569 CMS
AstraZeneca Pharmaceuticals LP $66.50 06/07/2024 Food and Beverage Undisputed 01/23/2026 1105470343 CMS
AstraZeneca Pharmaceuticals LP $23.06 06/07/2024 Food and Beverage Undisputed 01/23/2026 1105656960 CMS
AstraZeneca Pharmaceuticals LP $26.58 06/22/2024 Food and Beverage Undisputed 01/23/2026 1104777122 CMS
AstraZeneca Pharmaceuticals LP $14.96 07/18/2024 Food and Beverage Undisputed 01/23/2026 1105669493 CMS
AstraZeneca Pharmaceuticals LP $19.96 08/02/2024 Food and Beverage Undisputed 01/23/2026 1105648014 CMS
AstraZeneca Pharmaceuticals LP $14.60 08/02/2024 Food and Beverage Undisputed 01/23/2026 1105875511 CMS
AstraZeneca Pharmaceuticals LP $27.27 09/13/2024 Food and Beverage Undisputed 01/23/2026 1105511511 CMS
AstraZeneca Pharmaceuticals LP $14.01 09/13/2024 Food and Beverage Undisputed 01/23/2026 1105698784 CMS
AstraZeneca Pharmaceuticals LP $18.16 11/08/2024 Food and Beverage Undisputed 01/23/2026 1104234093 CMS
AstraZeneca Pharmaceuticals LP $16.15 11/22/2024 Food and Beverage Undisputed 01/23/2026 1104239571 CMS
AstraZeneca Pharmaceuticals LP $25.28 12/20/2024 Food and Beverage Undisputed 01/23/2026 1105851614 CMS
Bayer Healthcare Pharmaceuticals Inc. $32.35 12/19/2024 Food and Beverage Undisputed 01/23/2026 1086166112 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.26 04/02/2024 Food and Beverage Undisputed 01/23/2026 1118238912 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $30.27 06/07/2024 Food and Beverage Undisputed 01/23/2026 1118238914 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.23 08/13/2024 Food and Beverage Undisputed 01/23/2026 1118238910 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $32.47 11/22/2024 Food and Beverage Undisputed 01/23/2026 1118238916 CMS
Genentech USA, Inc. $22.64 04/27/2024 Food and Beverage Undisputed 01/23/2026 1133043964 CMS
GENZYME CORPORATION $15.74 08/30/2024 Food and Beverage Undisputed 01/23/2026 1139580914 CMS
GlaxoSmithKline, LLC. $5.83 02/06/2024 Food and Beverage Undisputed 01/23/2026 1116404949 CMS
GlaxoSmithKline, LLC. $6.79 02/09/2024 Food and Beverage Undisputed 01/23/2026 1116613286 CMS
GlaxoSmithKline, LLC. $23.64 03/01/2024 Food and Beverage Undisputed 01/23/2026 1116671508 CMS
GlaxoSmithKline, LLC. $6.28 04/16/2024 Food and Beverage Undisputed 01/23/2026 1116308257 CMS
GlaxoSmithKline, LLC. $12.69 04/19/2024 Food and Beverage Undisputed 01/23/2026 1116225997 CMS
GlaxoSmithKline, LLC. $14.24 04/23/2024 Food and Beverage Undisputed 01/23/2026 1116347824 CMS
GlaxoSmithKline, LLC. $27.45 05/09/2024 Food and Beverage Undisputed 01/23/2026 1115890828 CMS
GlaxoSmithKline, LLC. $12.75 06/14/2024 Food and Beverage Undisputed 01/23/2026 1116489070 CMS
GlaxoSmithKline, LLC. $12.34 08/08/2024 Food and Beverage Undisputed 01/23/2026 1116389308 CMS
GlaxoSmithKline, LLC. $7.32 09/17/2024 Food and Beverage Undisputed 01/23/2026 1116680289 CMS
GlaxoSmithKline, LLC. $3.23 09/20/2024 Food and Beverage Undisputed 01/23/2026 1115903171 CMS
GlaxoSmithKline, LLC. $19.55 09/26/2024 Food and Beverage Undisputed 01/23/2026 1116531668 CMS
GlaxoSmithKline, LLC. $3.24 10/01/2024 Food and Beverage Undisputed 01/23/2026 1116483721 CMS
GlaxoSmithKline, LLC. $8.52 12/03/2024 Food and Beverage Undisputed 01/23/2026 1116584771 CMS
GlaxoSmithKline, LLC. $7.06 12/12/2024 Food and Beverage Undisputed 01/23/2026 1116451859 CMS
Lilly USA, LLC $24.25 03/29/2024 Food and Beverage Undisputed 01/23/2026 1135117309 CMS
Merck Sharp & Dohme LLC $23.35 06/14/2024 Food and Beverage Undisputed 01/23/2026 1141734567 CMS
Merck Sharp & Dohme LLC $18.79 08/16/2024 Food and Beverage Undisputed 01/23/2026 1141882536 CMS
Mylan Specialty L.P. $31.17 03/15/2024 Food and Beverage Undisputed 01/23/2026 1147337362 CMS
Philips North America LLC $17.85 02/17/2024 Food and Beverage Undisputed 01/23/2026 1146879017 CMS
Regeneron Healthcare Solutions, Inc. $24.95 02/02/2024 Food and Beverage Undisputed 01/23/2026 1114142863 CMS
Regeneron Healthcare Solutions, Inc. $5.16 02/03/2024 Food and Beverage Undisputed 01/23/2026 1114142865 CMS
Regeneron Healthcare Solutions, Inc. $34.16 04/12/2024 Food and Beverage Undisputed 01/23/2026 1114142867 CMS
Regeneron Healthcare Solutions, Inc. $18.81 07/12/2024 Food and Beverage Undisputed 01/23/2026 1114142869 CMS
Regeneron Healthcare Solutions, Inc. $79.94 07/24/2024 Education Undisputed 01/23/2026 1114142871 CMS
Regeneron Healthcare Solutions, Inc. $17.38 08/02/2024 Food and Beverage Undisputed 01/23/2026 1114142873 CMS
Regeneron Healthcare Solutions, Inc. $19.28 09/27/2024 Food and Beverage Undisputed 01/23/2026 1114142875 CMS
Regeneron Healthcare Solutions, Inc. $39.55 10/26/2024 Food and Beverage Undisputed 01/23/2026 1114142877 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.